세계의 프로그래머블 주입 펌프 시장(2020-2024년)

※ 본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 프로그래머블 주입 펌프(Programmable Infusion Pumps) 시장은 만성 질환의 발병률 증가, 신제품 출시의 증가, 홈케어에서 자기 관리 약물전달의 수요 등의 성장 촉진 요인에 의해 예측 기간 중 약 8%의 CAGR로 확대될 전망입니다. 프로그래머블 주입 펌프에 관련된 고비용, 대체 약물전달 방법의 이용 가능성 및 빈번한 제품 리콜은 예측 기간 중 프로그램 주입 펌프 업계의 성장을 저해할 가능성이 있습니다.

세계의 프로그래머블 주입 펌프 시장에 대해 조사분석했으며, 시장 규모 및 성장률, 시장 동향, 시장 촉진 요인·과제, 시장 기회에 관한 검증, 주요 벤더 등에 관한 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 조사 범위

• 서론 1
• 서론 2
• 달러의 통화 환율

제3장 시장 상황

• 시장 에코시스템
• 시장의 특징
• 밸류체인 분석
• 시장 세분화 분석

제4장 시장 규모

• 시장의 정의
• 시장 규모(2019년)
• 시장 규모 및 예측(2019-2024년)
• 시장 전망

제5장 FIVE FORCES 분석

• 구매자의 교섭력
• 공급 업체의 교섭력
• 신규 진출의 위협
• 대체품의 위협
• 경쟁사의 위협
• 시장 현황

제6장 시장 세분화 : 유형별

• 시장 세분화 : 애플리케이션별
• 유형별 비교 : 시장 규모 및 예측(2019-2024년)
• 대용량 펌프
• 소용량 펌프
• 시장 기회 : 유형별

제7장 고객 상황

제8장 지역 상황

• 지역별 세분화
• 지역별 비교 : 시장 규모 및 예측(2019-2024년)
• 북미
• 유럽
• 아시아
• 기타 지역
• 주요 국가
• 시장 기회

제9장 의사결정 프레임워크

제10장 성장 요인과 과제

• 시장 성장 요인
• 시장의 과제

제11장 시장 동향

• 기술의 진보
• 인수의 증가
• 프로그래머블 주입 펌프에서 인터넷 접속의 성장

제12장 벤더 구도

• 개요
• 창조적 파괴 상황
• 경쟁 시나리오

제13장 벤더 분석

• 대상 벤더
• 벤더 분류
• 벤더의 시장 포지셔닝
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Co.
• Fresenius SE & Co. KGaA
• ICU Medical Inc.
• Johnson & Johnson
• Medtronic Plc
• Smiths Group Plc
• Terumo Corp.
• Ypsomed Holding AG

제14장 부록

• 조사 방법
• 약어 리스트
• 벤더의 시장 포지셔닝 정의

제15장 TECHNAVIO 소개

About this market

Technavio's programmable infusion pumps market analysis considers sales from large-volume infusion pumps and small-volume infusion pumps. Our study also finds the sales of programmable infusion pumps in Asia, Europe, North America, and ROW. In 2019, the large-volume infusion pumps segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as growing prevalence of chronic diseases and rising demand from outpatient facilities will play a significant role in the large-volume infusion pumps segment to maintain its market position. Also, our global programmable infusion pumps market report looks at factors such as increasing incidence of chronic diseases, rising number if new product launches, and demand for self-administered drug delivery in home-care settings. However, high costs associated with programmable infusion pumps, availability of alternative drug delivery methods, and frequent product recalls may hamper the growth of the programmable infusion pumps industry over the forecast period.

Overview

Growing demand for self-administered drug delivery in home-care settings

The rise in the number of people suffering from various medical conditions including arthritis diabetes and cancer, where the timing of the medication is an important and crucial factor has spurred the demand for self-administered drug delivery systems for use in home-care settings. The development of computerized ambulatory programmable drug infusion pumps has helped in the administration of antibiotics and various other categories of drugs. Companies operating in the global programmable infusion pumps market are focusing on developing ambulatory programmable drug infusion pumps to administer medications in home-care settings. This demand for self-administered drug delivery in home-care settings will lead to the expansion of the global programmable infusion pumps market at a CAGR of almost 8% during the forecast period.

Technological advances

Programmable infusion pumps are an advanced form of traditional infusion pumps, which are integrated with security software and drug libraries to provide standardized administration of drugs and nutrients, depending on the medical requirements of patients. Most pharmaceutical and medical devices companies are focusing on incorporating advanced technology in programmable infusion pumps to enhance their effectiveness, safety, and efficiency of the medication and minimize the risk of adverse reactions due to a drug overdose or underdose. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global programmable infusion pumps market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global programmable infusion pumps market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading programmable infusion pumps manufacturers, that include B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., Fresenius SE & Co. KGaA, ICU Medical Inc., Johnson & Johnson, Medtronic Plc, Smiths Group Plc, Terumo Corp., and Ypsomed Holding AG.

Also, the programmable infusion pumps market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY TYPE

• Market segmentation by type
• Comparison by type
• Large-volume infusion pumps - Market size and forecast 2019-2024
• Small-volume infusion pumps - Market size and forecast 2019-2024
• Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

• Technological advances
• Growing number of acquisitions
• Growing Internet connectivity in programmable infusion pumps

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Co.
• Fresenius SE & Co. KGaA
• ICU Medical Inc.
• Johnson & Johnson
• Medtronic Plc
• Smiths Group Plc
• Terumo Corp.
• Ypsomed Holding AG

PART 14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO